0001562180-22-004762.txt : 20220603 0001562180-22-004762.hdr.sgml : 20220603 20220603160833 ACCESSION NUMBER: 0001562180-22-004762 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weaver Dennis CENTRAL INDEX KEY: 0001844219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40154 FILM NUMBER: 22994422 MAIL ADDRESS: STREET 1: C/O OSCAR HEALTH, INC. STREET 2: 75 VARICK STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oscar Health, Inc. CENTRAL INDEX KEY: 0001568651 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 403-3677 MAIL ADDRESS: STREET 1: 75 VARICK STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: Mulberry Health Inc. DATE OF NAME CHANGE: 20130204 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-06-01 false 0001568651 Oscar Health, Inc. OSCR 0001844219 Weaver Dennis 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 false true false false Chief Clinical Officer Class A Common Stock 2022-06-01 4 M false 2004.00 A 15369.00 D Class A Common Stock 2022-06-01 4 M false 4167.00 A 19536.00 D Class A Common Stock 2022-06-02 4 S false 1548.00 4.6869 D 17988.00 D Restricted Stock Units 2022-06-01 4 M false 2004.00 0.00 D Class A Common Stock 2004.00 26059.00 D Restricted Stock Units 2022-06-01 4 M false 4167.00 0.00 D Class A Common Stock 4167.00 45834.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.741, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021. /s/ Melissa Curtin, Attorney-in-fact 2022-06-03